© 2008 AsiaPharm Biotech Pte Ltd (2007). All rights reserved.
AsiaPharm Biotech Pte Ltd (2007)
(formerly Wearnes Biotech & Medicals (1998) Pte Ltd)
(formerly Wearnes Biotech & Medicals (1998) Pte Ltd)
AsiaPharm Biotech Pte Ltd (2007) is now 100% owned by AsiaPharm Group Ltd, a public-listed company in Singapore and a leading pharmaceutical group in China.
AsiaPharm Biotech was formerly Wearnes Biotech & Medicals (1998) Pte Ltd, a member of WBL corporation (a Singapore-listed company), prior to the acquisition by AsiaPharm Group Ltd in 2007.
- Mission Statement
- Create a viable and profitable business in the development and marketing of evidence-based and safe natural medicines for the benefit of everybody.
- Business Objectives
- Our primary objective is to identify, commercialise and market evidence-based natural and traditional Chinese and oriental medicines. To achieve this objective, we are supported by the research and development departments in AsiaPharm’s diverse group of companies including WBL-Peking University Biotech Co., Ltd (WPU).
- We are also open to market external brands of natural products that are backed by strong clinical evidence.
- Business Activities
- Our business activities include product development, innovative marketing, e-health commerce, health publication, distribution of pharmaceutical and nutraceutical products and value-added investment.
HypoCol (pure strain red yeast rice) is an invention of the renowned Peking University, and is manufactured and distributed by AsiaPharm Biotech Pte Ltd (2007).
WBL-Peking University Biotech Co., Ltd (WPU) is a high-tech joint venture enterprise between the internationally renowned Peking University of China, Beijing Enterprises Holdings Limited and Singapore listed company, WBL Corporation Ltd. By combining advanced biotechnology and stringent quality control in its production process, consumers are always assured of only the best quality products from WPU.
WBL Corporation Ltd’s shares of the joint venture enterprise were acquired by AsiaPharm Group Ltd in 2007.
© 2008 AsiaPharm Biotech Ltd (2007). All rights reserved.
WBL-Peking University Biotech Co., Ltd (WPU) is a high-tech joint venture enterprise between the internationally renowned Peking University of China, Beijing Enterprises Holdings Limited and Singapore listed company, WBL Corporation Ltd. By combining advanced biotechnology and stringent quality control in its production process, consumers are always assured of only the best quality products from WPU.
WBL Corporation Ltd’s shares of the joint venture enterprise were acquired by AsiaPharm Group Ltd in 2007.
© 2008 AsiaPharm Biotech Ltd (2007). All rights reserved.